Doxazosin Tablet
NDC Package 53869-0076-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Doxazosin tablets is doxazosin is used alone or with other drugs to treat high blood pressure (hypertension). This formulation utilizes a tablet delivery system. Marketed by Pfizer Manufacturing Deutschland Gmbh, this product is identified by NDC 53869-0076.

Identification & Billing

NDC Package Code
53869-0076-1
Package Description
1 BAG in 1 DRUM / 83340 TABLET in 1 BAG
Product Code
53869-0076
11-Digit Billing Format
53869007601

Clinical Specifications

Proprietary Name
Doxazosin
Non-Proprietary Name
Doxazosin
Substance Name
Doxazosin Mesylate
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Active Ingredient(s)
DOXAZOSIN MESYLATE 4 mg/1
Usage Information
Doxazosin is used alone or with other drugs to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This medication works by relaxing blood vessels so blood can flow more easily. Doxazosin is also used in men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia-BPH). It does not shrink the prostate, but it works by relaxing the muscles in the prostate and part of the bladder. This helps to relieve symptoms of BPH such as difficulty in beginning the flow of urine, weak stream, and the need to urinate frequently or urgently (including during the middle of the night). Doxazosin belongs to a class of drugs known as alpha blockers.

Regulatory & Marketing

Labeler Name
Pfizer Manufacturing Deutschland Gmbh
Product Type
Drug For Further Processing
Marketing Category
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date
03-08-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 53869-0076-1 identifies a specific commercial package of 1 bag in 1 drum / 83340 tablet in 1 bag of Doxazosin (UNFINISHED drug), drug for further processing labeled by Pfizer Manufacturing Deutschland Gmbh. This tablet is formulated for use and contains doxazosin mesylate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Pfizer Manufacturing Deutschland Gmbh on March 08, 2025. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Doxazosin is used alone or with other drugs to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This medication works by relaxing blood vessels so blood can flow more easily. Doxazosin is also used in men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia-BPH). It does not shrink the prostate, but it works by relaxing the muscles in the prostate and part of the bladder. This helps to relieve symptoms of BPH such as difficulty in beginning the flow of urine, weak stream, and the need to urinate frequently or urgently (including during the middle of the night). Doxazosin belongs to a class of drugs known as alpha blockers.

How is this Pfizer Manufacturing Deutschland Gmbh product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 53869007601. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
53869-0076-1
11-Digit CMS (5-4-2)
53869-0076-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.